Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-Analysis

BACKGROUND AND AIMS: The clinical benefit of adjuvant antiviral therapy after curative therapy for HCC in patients with high preoperative HBV-DNA loads has been studied widely but that in patients with low preoperative HBV-DNA loads remains controversial. The purpose of this study was to determine t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Liu, Kai-Xuan, Hong, Jian-Guo, Wu, Rui, Dong, Zhao-Ru, Yang, Ya-Fei, Yan, Yu-Chuan, Yang, Chun-Cheng, Yan, Lun-Jie, Yao, Sheng-Yu, Li, Hai-Chao, Zhi, Xu-Ting, Li, Tao
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933452/
https://ncbi.nlm.nih.gov/pubmed/33680960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.605648
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky